{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:08:20Z","timestamp":1770163700880,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12503-z","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:21:15Z","timestamp":1767630075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug resistance patterns and associated risk factors in pulmonary tuberculosis patients from selected hospitals in Ghana"],"prefix":"10.1186","volume":"26","author":[{"given":"Michael","family":"Nkansah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Feglo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"12503_CR1","doi-asserted-by":"publisher","unstructured":"Goletti D, Meintjes G, Andrade BB, et al. Insights from the 2024 WHO Global Tuberculosis Report \u2013 More comprehensive action, innovation, and investments required for achieving WHO End TB goals. Int J Infect Dis; 150. https:\/\/doi.org\/10.1016\/j.ijid.2024.107325. Epub 2025 Jan 1.","DOI":"10.1016\/j.ijid.2024.107325"},{"key":"12503_CR2","unstructured":"Anonim. WHO treatment guidelines for drug-resistant tuberculosis. 2016."},{"key":"12503_CR3","doi-asserted-by":"publisher","first-page":"1800098","DOI":"10.1183\/13993003.00098-2018","volume":"51","author":"C Gilpin","year":"2018","unstructured":"Gilpin C, Korobitsyn A, Migliori GB, et al. The world health organization standards for tuberculosis care and management. Eur Respir J. 2018;51:1800098.","journal-title":"Eur Respir J"},{"key":"12503_CR4","unstructured":"WHO. 2024 Global tuberculosis report. 2024."},{"key":"12503_CR5","doi-asserted-by":"publisher","first-page":"e0013204","DOI":"10.1371\/journal.pntd.0013204","volume":"19","author":"ET Abbew","year":"2025","unstructured":"Abbew ET, Laryea R, Kwakye AO, et al. Treatment outcomes of multi-drug-resistant and rifampicin-resistant tuberculosis with and without isolation of nontuberculous mycobacteria between 2018\u20132021: A retrospective cohort study in Ghana. PLoS Negl Trop Dis. 2025;19:e0013204.","journal-title":"PLoS Negl Trop Dis"},{"key":"12503_CR6","doi-asserted-by":"publisher","unstructured":"Abdul IW, Ankamah S, Iddrisu AK, et al. Space-time analysis and mapping of prevalence rate of tuberculosis in Ghana. Sci Afr; 7. Epub ahead of print 1 March 2020. https:\/\/doi.org\/10.1016\/j.sciaf.2020.e00307.","DOI":"10.1016\/j.sciaf.2020.e00307"},{"key":"12503_CR7","unstructured":"WHO. Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"key":"12503_CR8","doi-asserted-by":"publisher","unstructured":"Sylverken AA, Kwarteng A, Twumasi-Ankrah S, et al. The burden of drug resistance tuberculosis in Ghana; results of the first national survey. PLoS ONE; 16. Epub ahead of print 1 June 2021. https:\/\/doi.org\/10.1371\/journal.pone.0252819.","DOI":"10.1371\/journal.pone.0252819"},{"key":"12503_CR9","doi-asserted-by":"publisher","unstructured":"Otchere ID, Morgan PA, Asare P, et al. Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases. Front Microbiol; 13. Epub ahead of print 12 January 2023. https:\/\/doi.org\/10.3389\/fmicb.2022.1069292.","DOI":"10.3389\/fmicb.2022.1069292"},{"key":"12503_CR10","doi-asserted-by":"publisher","unstructured":"Otchere ID, Asante-Poku A, Akpadja KF, et al. Opinion review of drug-resistant tuberculosis in West africa: tackling the challenges for effective control. Front Public Health; 12. Epub ahead of print 2024. https:\/\/doi.org\/10.3389\/fpubh.2024.1374703.","DOI":"10.3389\/fpubh.2024.1374703"},{"key":"12503_CR11","doi-asserted-by":"publisher","unstructured":"Der JB, Grant AD, Grint D, et al. Barriers to tuberculosis case finding in primary and secondary health facilities in Ghana: perceptions, experiences and practices of healthcare workers. BMC Health Serv Res; 22. Epub ahead of print 1 December 2022. https:\/\/doi.org\/10.1186\/s12913-022-07711-1.","DOI":"10.1186\/s12913-022-07711-1"},{"key":"12503_CR12","doi-asserted-by":"publisher","unstructured":"Osei E, Oppong S, Adanfo D, et al. Reflecting on tuberculosis case notification and treatment outcomes in the Volta region of Ghana: a retrospective pool analysis of a multicentre cohort from 2013 to 2017. Glob Health Res Policy; 4. Epub ahead of print 1 December 2019. https:\/\/doi.org\/10.1186\/s41256-019-0128-9.","DOI":"10.1186\/s41256-019-0128-9"},{"key":"12503_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.12688\/f1000research.109053.1","volume":"11","author":"A-K Iddrisu","year":"2022","unstructured":"Iddrisu A-K, Amikiya A, Kwame Bukari E. Spatio-temporal characteristics of tuberculosis in Ghana. F1000Res. 2022;11:200.","journal-title":"F1000Res"},{"key":"12503_CR14","doi-asserted-by":"publisher","unstructured":"Agyapong CA, Parsa AD, Hayhoe R, et al. Geospatial distribution of tuberculosis incidence and determinants of tuberculosis treatment outcomes in Nzema East Municipality, Ghana. Public Health Chall; 4. Epub ahead of print 1 September 2025. https:\/\/doi.org\/10.1002\/puh2.70108.","DOI":"10.1002\/puh2.70108"},{"key":"12503_CR15","doi-asserted-by":"publisher","unstructured":"Kuupiel D, Cheabu BSN, Yeboah P, et al. Geographic availability of and physical accessibility to tuberculosis diagnostic tests in Ghana: a cross-sectional survey. BMC Health Serv Res; 23. Epub ahead of print 1 December 2023. https:\/\/doi.org\/10.1186\/s12913-023-09755-3.","DOI":"10.1186\/s12913-023-09755-3"},{"key":"12503_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4236\/jtr.2018.62013","volume":"06","author":"KK Addo","year":"2018","unstructured":"Addo KK, Ampofo WK, Owusu R, et al. First nationwide survey of the prevalence of TB\/HIV Co-Infection in Ghana. J Tuberc Res. 2018;06:135\u201347.","journal-title":"J Tuberc Res"},{"key":"12503_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tube.2016.05.014","volume":"99","author":"ID Otchere","year":"2016","unstructured":"Otchere ID, Asante-Poku A, Osei-Wusu S, et al. Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana. Tuberculosis. 2016;99:147\u201354.","journal-title":"Tuberculosis"},{"key":"12503_CR18","doi-asserted-by":"publisher","unstructured":"ECDC. Handbook on TB laboratory diagnostic methods in the European Union. 2016. Epub ahead of print 2016. https:\/\/doi.org\/10.2900\/216384.Catalogue.","DOI":"10.2900\/216384.Catalogue"},{"key":"12503_CR19","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/infdis\/jiy454","volume":"218","author":"KN Nelson","year":"2018","unstructured":"Nelson KN, Shah NS, Mathema B, et al. Spatial patterns of extensively Drug-Resistant tuberculosis transmission in KwaZulu-Natal, South Africa. J Infect Dis. 2018;218:1964\u201373.","journal-title":"J Infect Dis"},{"key":"12503_CR20","doi-asserted-by":"publisher","unstructured":"Djochie RDA, Anto BP, Opare-Addo MNA, et al. Factors influencing treatment success in drug-susceptible tuberculosis patients in Ghana: a prospective cohort study. PLOS Global Public Health; 5. Epub ahead of print 21 February 2025. https:\/\/doi.org\/10.1371\/journal.pgph.0004146.","DOI":"10.1371\/journal.pgph.0004146"},{"key":"12503_CR21","doi-asserted-by":"publisher","unstructured":"Agyare E, Acolatse JEE, Dakorah MP, et al. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: a point prevalence survey study. PLoS ONE; 19. Epub ahead of print 1 January 2024. https:\/\/doi.org\/10.1371\/journal.pone.0297626.","DOI":"10.1371\/journal.pone.0297626"},{"key":"12503_CR22","doi-asserted-by":"publisher","unstructured":"Wang Y, Liu Q, Chen Z, et al. Disparities in the burden of tuberculosis associated with urbanization across 178 countries and territories: an observational study. Front Public Health. 2025;13. https:\/\/doi.org\/10.3389\/fpubh.2025.1658814.","DOI":"10.3389\/fpubh.2025.1658814"},{"key":"12503_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/HIV.S193059","volume":"12","author":"A Singh","year":"2020","unstructured":"Singh A, Prasad R, Balasubramanian V, et al. Drug-resistant tuberculosis and Hiv infection: current perspectives. HIV\/AIDS - Res Palliat Care. 2020;12:9\u201331.","journal-title":"HIV\/AIDS - Res Palliat Care"},{"key":"12503_CR24","doi-asserted-by":"publisher","unstructured":"Gehre F, Otu J, Kendall L, et al. The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillance. BMC Med; 14. Epub ahead of print 3 November 2016. https:\/\/doi.org\/10.1186\/s12916-016-0704-5.","DOI":"10.1186\/s12916-016-0704-5"},{"key":"12503_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4236\/jtr.2017.52012","volume":"05","author":"S Maharjan","year":"2017","unstructured":"Maharjan S, Singh A, Khadka DK, et al. Drug resistance pattern in pulmonary tuberculosis patients and risk factors associated with Multi-Drug resistant tuberculosis. J Tuberc Res. 2017;05:106\u201317.","journal-title":"J Tuberc Res"},{"key":"12503_CR26","doi-asserted-by":"publisher","unstructured":"Kerubo G, Amukoye E, Niemann S, et al. Drug susceptibility profiles of pulmonary Mycobacterium tuberculosis isolates from patients in informal urban settlements in Nairobi, Kenya. BMC Infect Dis; 16. Epub ahead of print 19 October 2016. https:\/\/doi.org\/10.1186\/s12879-016-1920-5.","DOI":"10.1186\/s12879-016-1920-5"},{"key":"12503_CR27","doi-asserted-by":"publisher","unstructured":"Loiseau C, Windels EM, Gygli SM, et al. The relative transmission fitness of multidrug-resistant Mycobacterium tuberculosis in a drug resistance hotspot. Nat Commun; 14. Epub ahead of print 1 December 2023. https:\/\/doi.org\/10.1038\/s41467-023-37719-y.","DOI":"10.1038\/s41467-023-37719-y"},{"key":"12503_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","volume":"18","author":"HH Kyu","year":"2018","unstructured":"Kyu HH, Maddison ER, Henry NJ, et al. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18:261\u201384.","journal-title":"Lancet Infect Dis"},{"key":"12503_CR29","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.ijid.2022.03.016","volume":"124","author":"S Osei-Wusu","year":"2022","unstructured":"Osei-Wusu S, Otchere ID, Asare P, et al. Relevance of genomic diversity of Mycobacterium tuberculosis complex in Africa. Int J Infect Dis. 2022;124:S47\u20139.","journal-title":"Int J Infect Dis"},{"key":"12503_CR30","doi-asserted-by":"publisher","unstructured":"Ochang EA, Udoh UA, Otu AA, et al. Unmasking rifampicin mono-resistance in tuberculosis patients in Cross River State, Nigeria. Discover Public Health; 22. Epub ahead of print 1 December 2025. https:\/\/doi.org\/10.1186\/s12982-025-00926-7.","DOI":"10.1186\/s12982-025-00926-7"},{"key":"12503_CR31","doi-asserted-by":"publisher","unstructured":"Monde N, Zulu M, Tembo M, et al. Drug resistant tuberculosis in the Northern region of Zambia: a retrospective study. Front Trop Dis; 2. Epub ahead of print 2021. https:\/\/doi.org\/10.3389\/fitd.2021.735028.","DOI":"10.3389\/fitd.2021.735028"},{"key":"12503_CR32","doi-asserted-by":"publisher","unstructured":"Mvelase NR, Balakrishna Y, Lutchminarain K, et al. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis. BMJ Open; 9. Epub ahead of print 1 November 2019. https:\/\/doi.org\/10.1136\/bmjopen-2019-031663.","DOI":"10.1136\/bmjopen-2019-031663"},{"key":"12503_CR33","doi-asserted-by":"publisher","unstructured":"Lindsey JA, Easton AV, Modestil H, et al. Rifampin mono-resistant tuberculosis in New York City, 2010\u20132021: a retrospective case series. Open Forum Infect Dis; 10. Epub ahead of print 1 November 2023. https:\/\/doi.org\/10.1093\/ofid\/ofad534.","DOI":"10.1093\/ofid\/ofad534"},{"key":"12503_CR34","doi-asserted-by":"publisher","unstructured":"Malenfant JH, Brewer TF. Rifampicin Mono-resistant tuberculosis - a review of an uncommon but growing challenge for global tuberculosis control. Open Forum Infect Dis; 8. Epub ahead of print 1 February 2021. https:\/\/doi.org\/10.1093\/ofid\/ofab018.","DOI":"10.1093\/ofid\/ofab018"},{"key":"12503_CR35","doi-asserted-by":"publisher","unstructured":"Reta MA, Tamene BA, Abate BB, et al. Mycobacterium tuberculosis drug resistance in Ethiopia: an updated systematic review and meta-analysis. Trop Med Infect Dis; 7. Epub ahead of print 1 October 2022. https:\/\/doi.org\/10.3390\/tropicalmed7100300.","DOI":"10.3390\/tropicalmed7100300"},{"key":"12503_CR36","doi-asserted-by":"crossref","unstructured":"Salaam-Dreyer Z, Streicher EM, Sirgel FA, et al. Rifampicin-monoresistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa. Epidemiol Surveill. 2021. https:\/\/journals.asm.org\/journal\/aac.","DOI":"10.1101\/2021.06.14.21258812"},{"key":"12503_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.18231\/j.ijcbr.2023.048","volume":"10","author":"A Salim Al-Karawi","year":"2024","unstructured":"Salim Al-Karawi A, Kadhim AA, Kadum MM. Recent advances in tuberculosis: A comprehensive review of emerging trends in pathogenesis, diagnostics, treatment, and prevention. Int J Clin Biochem Res. 2024;10:262\u20139.","journal-title":"Int J Clin Biochem Res"},{"key":"12503_CR38","doi-asserted-by":"publisher","unstructured":"Naidoo K, Perumal R, Ngema SL et al. Rapid diagnosis of drug-resistant tuberculosis\u2013opportunities and challenges. Pathogens; 13. Epub ahead of print 1 January 2024. https:\/\/doi.org\/10.3390\/pathogens13010027.","DOI":"10.3390\/pathogens13010027"},{"key":"12503_CR39","unstructured":"WHO. Global tuberculosis reporT. 2022. http:\/\/apps.who.int\/bookorders."},{"key":"12503_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/IDR.S152720","volume":"11","author":"S Osei-wusu","year":"2018","unstructured":"Osei-wusu S, Omari MA, Asante-poku A, et al. Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case. Infect Drug Resist. 2018;11:239\u201346.","journal-title":"Infect Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12503-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12503-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12503-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:18:06Z","timestamp":1770121086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12503-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12503"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12503-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study, with reference number CHRPE\/AP\/609\/19, was granted by the Committee on Human Research, Publications, and Ethics (CHRPE), School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology (KNUST), in Kumasi, Ghana. Informed consent was obtained from each participant before their enrollment in the study. This research was conducted in accordance with the guidelines and regulations of CHRPE and the Declaration of Helsinki. All participant data were securely stored on encrypted, password-protected servers, with access granted only to authorized research personnel. Patient records were anonymized by removing all personal identifiers before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}